C - Chemistry – Metallurgy – 07 – C
Patent
C - Chemistry, Metallurgy
07
C
C07C 259/06 (2006.01) A61K 31/16 (2006.01) A61K 31/165 (2006.01) A61P 37/00 (2006.01) C07C 237/22 (2006.01)
Patent
CA 2389319
A compound of formula (I) wherein: R is isopropyl; n is 0; R1 is naphthylmethyl; R2 is t-butyl; and R3 is methyl; is useful in the treatment of disorders mediated by s-CD23.
L'invention concerne un composé de formule (I) dans laquelle R représente isopropyle, n correspond à 0, R?1¿ représente naphtylméthyle, R?2¿ représente t-butyle et R?3¿ représente méthyle, utile dans le traitement de troubles induits par le CD23 soluble.
Faller Andrew
Ward John Gerard
Gowling Lafleur Henderson Llp
Smithkline Beecham P.l.c.
LandOfFree
Hydroxamic acid derivative as inhibitor of the formation of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Hydroxamic acid derivative as inhibitor of the formation of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hydroxamic acid derivative as inhibitor of the formation of... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1538205